Epsilon M&A Deal Report - Zellbios

Transaction Multiples for the Valuation of Private Companies

Private Group led by DPE Deutsche Private Equity > Zellbios

Announced Date : 16 December 2013

Type : SBO (Secondary Buy Out) ,Exit

Deal Value : Yes

Acquirer : Private Group led by DPE Deutsche Private Equity

Target Zellbios

Target Country Luxembourg

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Founded in 2011 via the merger of the Italian Company Farmabios and the German firm PharmaZell, Zellbios manufactures niche active pharmaceutical ingredients (APIs), mostly off-paten ...

No EMAT : 63146

Transaction multiples available

EV/Sales EV/Gross Profit EV/EBITDA EV/EBIT Eq/PBT P/E Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating *

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1226

Example of comparable transactions on EMAT (same sub-sector):

Date Acquirer Target Country Multiples See details
13/03/2014 Charles River Laboratories International CRO services division of Galapagos NV (Argenta and BioFocus) Netherlands 0
06/01/2014 Henry Schein Five Arseus companies in Belgium, France and the Netherlands Belgium 0

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report
About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

Subscribe to EMAT database